Fungal infections, named mycosis, can cause severe invasive and systemic diseases that
can even lead to death. In recent years, epidemiological data have recorded an increase in …

Purpose Voriconazole, an antifungal drug, is metabolized by a cytochrome P450 isozyme.
Increased adverse effects are observed in Asians because of the high rate of poor …

Invasive fungal disease (IFD) due to moulds other than Aspergillus is a significant cause of
mortality in patients with malignancies or post haemopoietic stem cell transplantation. The …

Purpose of Review IA (invasive aspergillosis) caused by azole-resistant strains has been
associated with higher clinical burden and mortality rates. We review the current …

Over 95,000 renal transplantation procedures were completed in 2021. Invasive
aspergillosis (IA) affects about 1 in 250 to 1 in 43 renal transplant recipients. About 50% of …

The COVID-19 pandemic has highlighted the detrimental effect of secondary pathogens in
patients with a primary viral insult. In addition to superinfections with bacterial pathogens …

Nosocomial pneumonia, or hospital-acquired pneumonia (HAP), and ventilator-associated
pneumonia (VAP) are important health problems worldwide, with both being associated with …

Aspergillus fumigatus has been designated by the World Health Organization as a critical
priority fungal pathogen. Some commercially available diagnostics for many forms of …

Invasive fungal diseases (IFD) are serious infections associated with high mortality,
particularly in immunocompromised patients. The prescribing of antifungal agents to prevent …

The COVID-19 pandemic caused> 6 million deaths worldwide, often from respiratory failure.
Complications frequently occurred in hospitalized patients, particularly in the intensive care …